Organization
Universidad de Sevilla, Health & Territory Research (HTR), Sevilla, Spain
1 abstract
Abstract
ASSESSMENT OF THE COVID-19 PANDEMIC FROM THE PERSPECTIVE OF PEOPLE WITH RHEUMATIC MUSCULOSKELETAL DISEASES IN EUROPE. RESULTS FROM THE REUMAVID STUDY (PHASE 1)Org: Novartis Pharma AG, Hospital Universitario La Paz - CIBERONC, Universidad de Sevilla, Health & Territory Research (HTR), Sevilla, Spain, University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom,